Home
>
US Stocks
>
uniQure N.V.
uniQure N.V.
QURE

uniQure N.V.

$28.490.21%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
28.38
Today Low/High
28.27 / 28.84
52 Week Low/High
$25.8 / $52.19
P/E ratio
4.41
Market Cap
$1.34B

Company Details

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.
Organisation
uniQure N.V.
Employees
332
Industry
Health Technology

Discover more

Frequently Asked Questions

What is uniQure N.V. share price today

Can Indians buy uniQure N.V. shares?

How can I buy uniQure N.V. shares from India?

Can Fractional shares of uniQure N.V. be purchased?

What are the documents required to start investing in uniQure N.V. stocks?

We are a SEBI registered investement advisor